Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-338122
Filing Date
2017-11-09
Accepted
2017-11-09 08:39:58
Documents
61
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d200630d10q.htm 10-Q 785936
2 EX-31.1 d200630dex311.htm EX-31.1 7846
3 EX-31.2 d200630dex312.htm EX-31.2 7756
4 EX-32.1 d200630dex321.htm EX-32.1 5053
  Complete submission text file 0001193125-17-338122.txt   3822455

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT snna-20170930.xml EX-101.INS 475238
6 XBRL TAXONOMY EXTENSION SCHEMA snna-20170930.xsd EX-101.SCH 46070
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE snna-20170930_cal.xml EX-101.CAL 49894
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE snna-20170930_def.xml EX-101.DEF 223952
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE snna-20170930_lab.xml EX-101.LAB 413586
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snna-20170930_pre.xml EX-101.PRE 308560
Mailing Address 30699 RUSSELL RANCH ROAD, SUITE 140 WESTLAKE VILLAGE CA 91362
Business Address 30699 RUSSELL RANCH ROAD, SUITE 140 WESTLAKE VILLAGE CA 91362 (818) 629-2256
Sienna Biopharmaceuticals, Inc. (Filer) CIK: 0001656328 (see all company filings)

EIN.: 273364627 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-38155 | Film No.: 171188410
SIC: 2834 Pharmaceutical Preparations